{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:02:21Z","timestamp":1790834541038,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018620","name":"Guangxi Zhuang Autonomous Region Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115024","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T20:35:33Z","timestamp":1671136533000},"page":"115024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors"],"prefix":"10.1016","volume":"247","author":[{"given":"Jian","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benji","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangqi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quande","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keguang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouri","family":"Neamati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-9343","authenticated-orcid":false,"given":"Yanghan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115024_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81671-2","article-title":"An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing","volume":"99","author":"Tanny","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.115024_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2006.06.057","article-title":"SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic \u03b2 cells","volume":"126","author":"Haigis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.115024_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.18632\/aging.100389","article-title":"Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair","volume":"3","author":"Meter","year":"2011","journal-title":"Aging"},{"key":"10.1016\/j.ejmech.2022.115024_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","article-title":"Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins","volume":"273","author":"Frye","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.115024_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tig.2014.04.007","article-title":"Sirtuins: guardians of mammalian healthspan","volume":"30","author":"Giblin","year":"2014","journal-title":"Trends Genet."},{"key":"10.1016\/j.ejmech.2022.115024_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/ars.2014.6213","article-title":"Mitochondrial sirtuins and their relationships with metabolic disease and cancer","volume":"22","author":"Kumar","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2022.115024_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.1207861","article-title":"SIRT5 is a NAD-dependent protein lysine demalonylase and desuccinylase","volume":"334","author":"Du","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115024_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.exger.2014.12.004","article-title":"Mitochondrial sirtuins: emerging roles in metabolic regulations, energy homeostasis and diseases","volume":"61","author":"Parihar","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejmech.2022.115024_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2009.02.026","article-title":"SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle","volume":"137","author":"Nakagawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.115024_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molcel.2013.06.001","article-title":"SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways","volume":"50","author":"Park","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2022.115024_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2015.05.022","article-title":"SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target","volume":"59","author":"Nishida","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2022.115024_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15548627.2015.1009778","article-title":"SIRT5 regulation of ammonia-induced autophagy and mitophagy","volume":"11","author":"Polletta","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2022.115024_bib13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bbapap.2009.09.011","article-title":"Function and regulation of the mitochondrial sirtuin isoform SIRT5 in mammalia","volume":"1804","author":"Gertz","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2022.115024_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.10.033","article-title":"SIRT5 desuccinylates and activates SOD1 to eliminate ROS","volume":"441","author":"Lin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.115024_bib15","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/cr500457h","article-title":"Sirtuins in epigenetic regulation","volume":"115","author":"Jing","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.115024_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/ars.2017.7264","article-title":"Emerging roles for SIRT5 in metabolism and cancer","volume":"28","author":"Bringman-Rodenbarger","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2022.115024_bib17","doi-asserted-by":"crossref","first-page":"10699","DOI":"10.1007\/s13277-014-2372-4","article-title":"SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer","volume":"35","author":"Lu","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejmech.2022.115024_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138926","article-title":"The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics","volume":"131","author":"Giblin","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.115024_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1158\/0008-5472.CAN-17-1912","article-title":"SHMT2 desuccinylation by SIRT5 drives cancer cell proliferation","volume":"78","author":"Yang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.115024_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41467-018-02951-4","article-title":"Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.115024_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1878-0261.12408","article-title":"SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer","volume":"13","author":"Shi","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2022.115024_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2022.02.014","article-title":"Overexpression of SLC25A51 promotes hepatocellular carcinoma progression by driving aerobic glycolysis through activation of SIRT5","volume":"182","author":"Bai","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2022.115024_bib23","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/ja2090417","article-title":"Thiosuccinyl peptides as SIRT5-specific inhibitors","volume":"134","author":"He","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.115024_bib24","doi-asserted-by":"crossref","first-page":"10728","DOI":"10.1002\/anie.201402679","article-title":"Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors","volume":"53","author":"Roessler","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.115024_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ml3002709","article-title":"Inhibitors of the NAD+-dependent protein desuccinylase and demalonylase SIRT5","volume":"3","author":"Maurer","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115024_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bmcl.2012.10.136","article-title":"Inhibition of the human deacylase Sirtuin 5 by the indole GW5074","volume":"23","author":"Suenkel","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115024_bib27","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/jhet.2732","article-title":"Design and synthesis of new 9-substituted norharmane derivatives as potential SIRT5 inhibitors","volume":"54","author":"Yang","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/cbdd.13077","article-title":"Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors","volume":"91","author":"Liu","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.115024_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11427-016-0060-7","article-title":"Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors","volume":"60","author":"Yang","year":"2017","journal-title":"Sci. Ch. Life. Sci."},{"key":"10.1016\/j.ejmech.2022.115024_bib30","doi-asserted-by":"crossref","first-page":"14836","DOI":"10.1002\/anie.201709050","article-title":"Mechanism-based inhibitors of the human sirtuin 5 deacylase: structure-activity relationship, biostructural, and kinetic insight","volume":"56","author":"Rajabi","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.115024_bib31","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1021\/acs.jmedchem.7b01648","article-title":"Potent and selective inhibitors of human sirtuin 5","volume":"61","author":"Kalbas","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112676","article-title":"Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations","volume":"206","author":"Glas","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113803","article-title":"Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates","volume":"225","author":"Yang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/1573406415666190603101937","article-title":"Cyclic tripeptide-based potent and selective human SIRT5 inhibitors","volume":"16","author":"Jiang","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib35","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1021\/jm300526r","article-title":"Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme","volume":"55","author":"Madsen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib36","doi-asserted-by":"crossref","first-page":"36214","DOI":"10.1039\/C7RA05824A","article-title":"Interactions between sirtuins and fluorogenic small-molecule substrates offer insights into inhibitor design","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.115024_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.str.2007.02.002","article-title":"Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin","volume":"15","author":"Schuetz","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2022.115024_bib38","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.bmcl.2015.05.058","article-title":"Novel thiourea-based sirtuin inhibitory warheads","volume":"25","author":"Zang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115024_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2011.06.069","article-title":"A mechanism-based potent sirtuin inhibitor containing N\u03b5-thiocarbamoyl-lysine (TuAcK)","volume":"21","author":"Hirsch","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115024_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202115805","article-title":"Investigation of carboxylic acid isosteres and prodrugs for inhibition of the human SIRT5 lysine deacylase enzyme","volume":"61","author":"Rajabi","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.115024_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114363","article-title":"Overview of SIRT5 as a potential therapeutic target: structure, function and inhibitors","volume":"236","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114623","article-title":"Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors","volume":"241","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib43","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1021\/acs.jmedchem.2c00687","article-title":"Therapeutic potential and activity modulation of the protein lysine deacylase sirtuin 5","volume":"65","author":"Fiorentino","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115024_bib44","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/jm501123r","article-title":"Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents","volume":"58","author":"Stornaiuolo","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:43Z","timestamp":1759330003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"alternative-id":["S0223523422009266"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115024","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115024"}}